Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Interaction Study to Evaluate Changes in Blood Pressure Following 1, 1.5, 2, and 2.5 mg Riociguat Tid (Dose Titration) Compared to Placebo Treatment on the Background of Stable Sildenafil Pretreatment in Subjects With Symptomatic Pulmonary Arterial Hypertension

NCT01179334 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01179334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01179334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Interaction Study to Evaluate Changes in Blood Pressure Following 1, 1.5, 2, and 2.5 mg Riociguat Tid (Dose Titration) Compared to Placebo Treatment on the Background of Stable Sildenafil Pretreatment in Subjects With Symptomatic Pulmonary Arterial Hypertension
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2010
Completion date
May 31, 2013
Enrollment
18 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension